North West London Pebble Pathway: Automated OSA Diagnosis
Patrik Bachtiger
200 participants
Jul 7, 2024
INTERVENTIONAL
Conditions
Summary
Patients with obstructive sleep apnoea (OSA) wait up to two years for a diagnostic test. Early diagnosis enables optimal treatment, mitigating risks including heart failure, lung disease, and stroke. Current diagnostic approaches are expensive (£391), time-consuming (\>1-hour interpretation), uncomfortable (cables/tubes/wires), and inequitable (multiple hospital visits). Overcoming all these limitations, we have designed and will investigate a straigh-to-test automated diagnostic pathway for OSA. This will use the AcuPebble, a miniature wearable acoustic sensor and the first regulated technology for automated, at-home diagnosis. The test is cheap (\< £100); time-saving; endorsed by patients, and accessible (posted directly to patients). This project will measure the impact of a potentially transformative, innovative, and scalable diagnostic pathway using AcuPebble technology.
Eligibility
Inclusion Criteria1
- OSA testing referral from primary care
Exclusion Criteria1
- Unable to follow test instructions
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
At home testing for OSA with AcuPebble.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06507228